Quinazoline derivatives of formula (I): ##STR00001## wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.
Claims The invention claimed is: 1. A compound selected from any one of: N-(2,3-difluorophenyl)-2-{3-[(7-{[1-(2-hydroxyethyl)piperidin-4-yl]methox- y}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(3-hydroxy-1,1-dimethylpropyl)amino]p- ropoxy}quinazolin-4-yl)amino]-1 H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2S)-2-(2-hydroxyethyl)pyrrolidin-1-y- l]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(butyl)amino]propoxy}- -quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)am- ino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)am- ino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quina- zolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxy-1,1-dimethylethyl)amino]propox- y}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy}-qu- inazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{4-[(2-hydroxyethyl)(propyl)amino]butoxy}- -quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{4-[ethyl(2-hydroxyethyl)amino]butoxy}-quinaz- olin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{4-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]butoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{4-[(2-hydroxyethyl)(methyl)amino]butoxy}- quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]butoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3[ethyl(3-hydroxypropyl)amino]propoxy}-quinazolin-4-yl)amino]-1- H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino]pro- poxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; and 2-{3-[(7-{3[ethyl(2-hydroxyethyl)amino]propoxy}-6-fluoroquinazolin-4-yl)a- mino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; or a pharmaceutically acceptable salt thereof. 2. A compound which is N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quina- zolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide or a pharmaceutically acceptable salt thereof. 3. A pharmaceutical composition comprising a compound according to claim 1 or 2, or a pharmaceutically acceptable salt thereof. 